Itron, Inc. — Scientific & Technical Instruments. Scored on the same transparent 7-signal model behind the daily rankings.
★
ITRI
Itron, Inc. · Scientific & Technical Instruments
FCF$395mC
Rev-3.0%D+
D/E0.98C
P/E13.4xA-
PEG0.78A-
55.9Score
$84.99$3.8B
1Y Target$126.70Analyst consensus · 10 analysts
5Y Target$159.96Compound horizon
10Y Target$205.14Long-dated conviction
FCF$395mTTMC
FCF $395m — modest; watch for margin expansion
Rev-3.0%TTM YoYD+
Revenue -3.0% — shrinking; needs a catalyst to reverse
D/E0.98C
D/E 0.98 — more levered than most Technology peers (≈90th pctile)
P/E13.4xA-
P/E 13.4 — cheaper than most Technology peers (≈25th pctile)
PEG0.78A-
PEG 0.78 — strong; Lynch's preferred zone
Forward price target — the 1-year figure is the analyst consensus where the stock is covered; the 5- and 10-year figures compound our earnings estimate from there. The DCF below is a separate cross-check on intrinsic value (what it's worth today), not another target.
Quality-growth score · 55.9
Quality0.64
Growth0.32
Value0.85
Why this score
Buying back stock
Entry · Margin of safety
52-week rangeNear 52-week low
40% off the 12-month high
vs DCF fair value30% belowest. fair value ~$122
Quality signals · context only
Gross profitability23% · Bgross profit ÷ total assets (Novy-Marx)
ROIC7.6% · C+return on invested capital — not score-weighted
Why now
Scientific & Technical Instruments · market cap $3.8b. Down 40% from 52-week high of $142.00 — deep drawdown territory. PEG 0.78 — paying under fair value for the growth rate. 10 sell-side analysts publish a mean 1-yr target of $126.70 (implying +49% upside).
Moat
Net margin 12% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 137% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 40% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $126.70 (10-analyst consensus) — multiple re-rating thesis requires a catalyst. 5 yr $159.96 at ~13% CAGR — dividend + buyback compounding. 10 yr $205.14 if the moat survives secular pressure.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Position sizing · ITRI
$
%
%
Shares to buy
23
Position size
$1,955
3.9% of portfolio
Stop price
$63.74
25% below $84.99
$ at risk if stopped
$488.69
budget $500.00 · 1% of portfolio
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Itron, Inc. (ITRI): score, valuation & FAQ
Itron, Inc. (ITRI) is a Scientific & Technical Instruments company that scores 55.9 out of 100 on the Bull Rankings quality-growth model — a middling reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are P/E (A-) and PEG (A-), while Rev (D+) rate weaker. On valuation, ITRI sits about 30% below our discounted-cash-flow fair value (a margin of safety).
Is ITRI a good stock to buy?
Bull Rankings scores ITRI 55.9 out of 100 on its quality-growth model, which is a middling reading. That is driven by P/E (A-) and PEG (A-). A score is a quantitative screen of Itron, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does ITRI score 55.9 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). ITRI earns its highest marks on P/E (A-) and PEG (A-), and is held back by Rev (D+). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is ITRI overvalued or undervalued?
Based on $84.99, ITRI sits about 30% below our discounted-cash-flow fair value (a margin of safety). It trades at a 13.4x× P/E (graded A-). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in ITRI?
Down 40% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.